nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Paresis—Vincristine—muscle cancer	0.0352	0.0352	CcSEcCtD
Gadodiamide—Paresis—Methotrexate—muscle cancer	0.0171	0.0171	CcSEcCtD
Gadodiamide—Warmth—Doxorubicin—muscle cancer	0.017	0.017	CcSEcCtD
Gadodiamide—Extravasation—Dactinomycin—muscle cancer	0.0165	0.0165	CcSEcCtD
Gadodiamide—Extravasation—Vincristine—muscle cancer	0.0147	0.0147	CcSEcCtD
Gadodiamide—Rigors—Etoposide—muscle cancer	0.0127	0.0127	CcSEcCtD
Gadodiamide—Phlebitis—Dactinomycin—muscle cancer	0.0121	0.0121	CcSEcCtD
Gadodiamide—Extravasation—Etoposide—muscle cancer	0.0119	0.0119	CcSEcCtD
Gadodiamide—Cardiovascular disorder—Etoposide—muscle cancer	0.0118	0.0118	CcSEcCtD
Gadodiamide—Coma—Vincristine—muscle cancer	0.0117	0.0117	CcSEcCtD
Gadodiamide—Venous thrombosis—Doxorubicin—muscle cancer	0.01	0.01	CcSEcCtD
Gadodiamide—Encephalopathy—Methotrexate—muscle cancer	0.00971	0.00971	CcSEcCtD
Gadodiamide—Hyponatraemia—Vincristine—muscle cancer	0.00936	0.00936	CcSEcCtD
Gadodiamide—Lung disorder—Methotrexate—muscle cancer	0.00881	0.00881	CcSEcCtD
Gadodiamide—Ataxia—Vincristine—muscle cancer	0.00877	0.00877	CcSEcCtD
Gadodiamide—Phlebitis—Etoposide—muscle cancer	0.00877	0.00877	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Etoposide—muscle cancer	0.0078	0.0078	CcSEcCtD
Gadodiamide—Cardiac failure—Etoposide—muscle cancer	0.00774	0.00774	CcSEcCtD
Gadodiamide—Lung disorder—Doxorubicin—muscle cancer	0.00762	0.00762	CcSEcCtD
Gadodiamide—Pharyngitis—Dactinomycin—muscle cancer	0.00717	0.00717	CcSEcCtD
Gadodiamide—Extravasation—Methotrexate—muscle cancer	0.00714	0.00714	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Vincristine—muscle cancer	0.00708	0.00708	CcSEcCtD
Gadodiamide—Rash erythematous—Doxorubicin—muscle cancer	0.00705	0.00705	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Vincristine—muscle cancer	0.00704	0.00704	CcSEcCtD
Gadodiamide—Myocardial infarction—Vincristine—muscle cancer	0.00704	0.00704	CcSEcCtD
Gadodiamide—Feeling hot—Doxorubicin—muscle cancer	0.00688	0.00688	CcSEcCtD
Gadodiamide—Flushing—Dactinomycin—muscle cancer	0.0067	0.0067	CcSEcCtD
Gadodiamide—Ageusia—Doxorubicin—muscle cancer	0.00666	0.00666	CcSEcCtD
Gadodiamide—Rigors—Doxorubicin—muscle cancer	0.00661	0.00661	CcSEcCtD
Gadodiamide—Injection site pain—Doxorubicin—muscle cancer	0.00661	0.00661	CcSEcCtD
Gadodiamide—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00659	0.00659	CcSEcCtD
Gadodiamide—Chills—Dactinomycin—muscle cancer	0.00648	0.00648	CcSEcCtD
Gadodiamide—Bronchospasm—Etoposide—muscle cancer	0.00642	0.00642	CcSEcCtD
Gadodiamide—Hallucination—Vincristine—muscle cancer	0.00642	0.00642	CcSEcCtD
Gadodiamide—Urinary tract disorder—Vincristine—muscle cancer	0.00637	0.00637	CcSEcCtD
Gadodiamide—Sweating increased—Etoposide—muscle cancer	0.00636	0.00636	CcSEcCtD
Gadodiamide—Urethral disorder—Vincristine—muscle cancer	0.00632	0.00632	CcSEcCtD
Gadodiamide—Extravasation—Doxorubicin—muscle cancer	0.00619	0.00619	CcSEcCtD
Gadodiamide—Vasodilation procedure—Doxorubicin—muscle cancer	0.00614	0.00614	CcSEcCtD
Gadodiamide—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00614	0.00614	CcSEcCtD
Gadodiamide—Vasodilation—Doxorubicin—muscle cancer	0.00614	0.00614	CcSEcCtD
Gadodiamide—Melaena—Methotrexate—muscle cancer	0.00609	0.00609	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00583	0.00583	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Etoposide—muscle cancer	0.00574	0.00574	CcSEcCtD
Gadodiamide—Renal failure—Etoposide—muscle cancer	0.00572	0.00572	CcSEcCtD
Gadodiamide—Myocardial infarction—Etoposide—muscle cancer	0.00571	0.00571	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Etoposide—muscle cancer	0.00571	0.00571	CcSEcCtD
Gadodiamide—Coma—Methotrexate—muscle cancer	0.00569	0.00569	CcSEcCtD
Gadodiamide—Malaise—Dactinomycin—muscle cancer	0.00567	0.00567	CcSEcCtD
Gadodiamide—Coordination abnormal—Doxorubicin—muscle cancer	0.0055	0.0055	CcSEcCtD
Gadodiamide—Injection site reaction—Doxorubicin—muscle cancer	0.00536	0.00536	CcSEcCtD
Gadodiamide—Myalgia—Dactinomycin—muscle cancer	0.00535	0.00535	CcSEcCtD
Gadodiamide—Eructation—Doxorubicin—muscle cancer	0.0053	0.0053	CcSEcCtD
Gadodiamide—Discomfort—Dactinomycin—muscle cancer	0.00529	0.00529	CcSEcCtD
Gadodiamide—Melaena—Doxorubicin—muscle cancer	0.00527	0.00527	CcSEcCtD
Gadodiamide—Urinary tract disorder—Etoposide—muscle cancer	0.00516	0.00516	CcSEcCtD
Gadodiamide—Oedema—Dactinomycin—muscle cancer	0.00513	0.00513	CcSEcCtD
Gadodiamide—Urethral disorder—Etoposide—muscle cancer	0.00512	0.00512	CcSEcCtD
Gadodiamide—Infection—Dactinomycin—muscle cancer	0.0051	0.0051	CcSEcCtD
Gadodiamide—Coma—Doxorubicin—muscle cancer	0.00493	0.00493	CcSEcCtD
Gadodiamide—Renal failure acute—Methotrexate—muscle cancer	0.0049	0.0049	CcSEcCtD
Gadodiamide—Convulsion—Vincristine—muscle cancer	0.00486	0.00486	CcSEcCtD
Gadodiamide—Flushing—Etoposide—muscle cancer	0.00485	0.00485	CcSEcCtD
Gadodiamide—Myalgia—Vincristine—muscle cancer	0.00478	0.00478	CcSEcCtD
Gadodiamide—Visual disturbance—Methotrexate—muscle cancer	0.00477	0.00477	CcSEcCtD
Gadodiamide—Abnormal vision—Doxorubicin—muscle cancer	0.00471	0.00471	CcSEcCtD
Gadodiamide—Chills—Etoposide—muscle cancer	0.00469	0.00469	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00467	0.00467	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00467	0.00467	CcSEcCtD
Gadodiamide—Anaphylactic shock—Vincristine—muscle cancer	0.00458	0.00458	CcSEcCtD
Gadodiamide—Oedema—Vincristine—muscle cancer	0.00458	0.00458	CcSEcCtD
Gadodiamide—Infection—Vincristine—muscle cancer	0.00455	0.00455	CcSEcCtD
Gadodiamide—Phlebitis—Doxorubicin—muscle cancer	0.00455	0.00455	CcSEcCtD
Gadodiamide—Nervous system disorder—Vincristine—muscle cancer	0.00449	0.00449	CcSEcCtD
Gadodiamide—Dysgeusia—Etoposide—muscle cancer	0.00445	0.00445	CcSEcCtD
Gadodiamide—Hyperhidrosis—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—muscle cancer	0.00442	0.00442	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—muscle cancer	0.00439	0.00439	CcSEcCtD
Gadodiamide—Hypotension—Vincristine—muscle cancer	0.00428	0.00428	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—muscle cancer	0.00425	0.00425	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—muscle cancer	0.00424	0.00424	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—muscle cancer	0.00423	0.00423	CcSEcCtD
Gadodiamide—Ill-defined disorder—Etoposide—muscle cancer	0.00422	0.00422	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00419	0.00419	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—muscle cancer	0.00419	0.00419	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00418	0.00418	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—muscle cancer	0.00415	0.00415	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—muscle cancer	0.00412	0.00412	CcSEcCtD
Gadodiamide—Paraesthesia—Vincristine—muscle cancer	0.00411	0.00411	CcSEcCtD
Gadodiamide—Malaise—Etoposide—muscle cancer	0.0041	0.0041	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—muscle cancer	0.00405	0.00405	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—muscle cancer	0.00405	0.00405	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00405	0.00405	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—muscle cancer	0.00401	0.00401	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—muscle cancer	0.004	0.004	CcSEcCtD
Gadodiamide—Fatigue—Vincristine—muscle cancer	0.00395	0.00395	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—muscle cancer	0.00394	0.00394	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—muscle cancer	0.00393	0.00393	CcSEcCtD
Gadodiamide—Pain—Vincristine—muscle cancer	0.00392	0.00392	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—muscle cancer	0.00386	0.00386	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—muscle cancer	0.00383	0.00383	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—muscle cancer	0.00378	0.00378	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vincristine—muscle cancer	0.00375	0.00375	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—muscle cancer	0.00371	0.00371	CcSEcCtD
Gadodiamide—Infection—Etoposide—muscle cancer	0.00369	0.00369	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—muscle cancer	0.00368	0.00368	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—muscle cancer	0.00368	0.00368	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—muscle cancer	0.00367	0.00367	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—muscle cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Abdominal pain—Vincristine—muscle cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Body temperature increased—Vincristine—muscle cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—muscle cancer	0.00351	0.00351	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—muscle cancer	0.00347	0.00347	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—muscle cancer	0.00343	0.00343	CcSEcCtD
Gadodiamide—Hypersensitivity—Vincristine—muscle cancer	0.00338	0.00338	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—muscle cancer	0.0033	0.0033	CcSEcCtD
Gadodiamide—Asthenia—Vincristine—muscle cancer	0.00329	0.00329	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—muscle cancer	0.00326	0.00326	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—muscle cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—muscle cancer	0.0032	0.0032	CcSEcCtD
Gadodiamide—Pain—Etoposide—muscle cancer	0.00317	0.00317	CcSEcCtD
Gadodiamide—Diarrhoea—Vincristine—muscle cancer	0.00314	0.00314	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—muscle cancer	0.00311	0.00311	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—muscle cancer	0.00307	0.00307	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—muscle cancer	0.00306	0.00306	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—muscle cancer	0.00305	0.00305	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—muscle cancer	0.00304	0.00304	CcSEcCtD
Gadodiamide—Dizziness—Vincristine—muscle cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—muscle cancer	0.00302	0.00302	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00296	0.00296	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—muscle cancer	0.00295	0.00295	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—muscle cancer	0.00292	0.00292	CcSEcCtD
Gadodiamide—Vomiting—Vincristine—muscle cancer	0.00291	0.00291	CcSEcCtD
Gadodiamide—Rash—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Dermatitis—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Headache—Vincristine—muscle cancer	0.00287	0.00287	CcSEcCtD
Gadodiamide—Chills—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Gadodiamide—Nausea—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—muscle cancer	0.00272	0.00272	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—muscle cancer	0.00266	0.00266	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—muscle cancer	0.00254	0.00254	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—muscle cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Rash—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Headache—Etoposide—muscle cancer	0.00233	0.00233	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Infection—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Gadodiamide—Nausea—Etoposide—muscle cancer	0.00221	0.00221	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Pain—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Rash—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Headache—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
